Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F. Kodera Y, et al. Among authors: kawa k. Bone Marrow Transplant. 1999 Nov;24(9):995-1003. doi: 10.1038/sj.bmt.1702027. Bone Marrow Transplant. 1999. PMID: 10556959
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y. Morishima Y, et al. Among authors: kawa k. Blood. 2002 Jun 1;99(11):4200-6. doi: 10.1182/blood.v99.11.4200. Blood. 2002. PMID: 12010826 Free article.
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Kanda Y, Izutsu K, Hirai H, Sakamaki H, Iseki T, Kodera Y, Okamoto S, Mitsui H, Iwato K, Hirabayashi N, Furukawa T, Maruta A, Kasai M, Atsuta Y, Hamajima N, Hiraoka A, Kawa K. Kanda Y, et al. Among authors: kawa k. Leukemia. 2004 May;18(5):1013-9. doi: 10.1038/sj.leu.2403343. Leukemia. 2004. PMID: 15029208
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation.
Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T, Sao H, Kodera Y, Hirabayashi N, Okamoto S, Harada M, Iwato K, Maruta A, Tanimoto M, Kawa K; Japan Society for Hematopoietic Cell Transplantation. Ogawa H, et al. Among authors: kawa k. Int J Hematol. 2004 Jun;79(5):495-500. doi: 10.1532/ijh97.03166. Int J Hematol. 2004. PMID: 15239403
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C, Mukai H, Takenaka K, Yoshino T, Tsuzuki T, Sugimori H, Kawa K, Kodera Y, Oshimi K; NK-cell Tumor Study Group. Suzuki R, et al. Among authors: kawa k. Bone Marrow Transplant. 2006 Feb;37(4):425-31. doi: 10.1038/sj.bmt.1705244. Bone Marrow Transplant. 2006. PMID: 16400344
Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S, Kawa K, Kojima S, Morishima Y, Morishita Y, Nakahata T, Okamura J, Okamoto S, Shiobara S, Tanimoto M, Tsuchida M, Atsuta Y, Yamamoto K, Tanaka J, Hamajima N, Kodera Y. Imamura M, et al. Among authors: kawa k. Int J Hematol. 2006 Feb;83(2):164-78. doi: 10.1532/IJH97.05134. Int J Hematol. 2006. PMID: 16513537
241 results